PMCB
PharmaCyte Biotech Inc

5,591
Loading...
Loading...
News
all
press releases
News Placeholder
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (MyMD) a clinical stage biopharmaceutical...
Business Wire·1y ago
News Placeholder
PharmaCyte Biotech (NASDAQ:PMCB) Trading Down 1.6%
PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report)s stock price dropped 1.6% during mid-day trading on Tuesday . The stock traded as low as $2.34 and last traded at $2.44...
Zolmax·2y ago
News Placeholder
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Sees Significant Drop in Short Interest
PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 26,500 shares, a...
Ticker Report·2y ago

Latest PMCB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.